Report post

When will Aeterna Zentaris merge with a diversified biopharmaceutical company?

Corporate: Announced on March 12, 2024 approval of merger with Aeterna Zentaris by Securityholders at special meeting. Received on March 28, 2024 the final court approval for merger with AeternaZentaris to create a diversified biopharmaceutical company; expected to close in the second quarter of 2024; subject to the closing conditions.

Who is Aeterna Zentaris?

About Aeterna Zentaris Inc. Aeterna is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of significant unmet medical need.

What is the redemption date for Aeterna Zentaris common shares?

The Company would also like to clarify that the redemption date for the due bills attaching to the Company’s common shares as a result of the previously announced warrant issuance is June 3, 2024. About Aeterna Zentaris Inc.

The World's Leading Crypto Trading Platform

Get my welcome gifts